We’re excited to share that Lumea will be participating as a Technology Partner and Exhibitor at the upcoming Transforming Digital Pathology & AI: The Path Forward conference, taking place on…
Read More
The future of pathology isn’t just digital—it’s integrated. As precision medicine continues to advance, the need for seamless coordination between pathology and molecular diagnostics has never been greater. However, traditional…
A Summary of Staci Kearney’s presentation at the Digital Diagnostic Summit 2024 The Current State of the FDA’s Final Rule On May 6, 2024, the FDA issued its final rule…
AI has been a huge buzzword in pathology, but are the benefits worth the hype for prostate cancer? It’s true that AI can enhance digital prostate pathology by supporting diagnostic…
Laboratories worldwide are united by a commitment to excellence, whether in service, research, or the quality of their slides. However, beneath this shared dedication lies a diversity of resources, tools,…
“We’re all doctors. We all got into this field for a reason: the patient is central to everything we do. Using Lumea technology simply results in a better end product…
In this episode, Dr. Matthew O. Leavitt takes us through his digital pathology journey and what he’s learned along the way. Dr. Leavitt’s vision has always been to use digital…
LEHI, UT, UNITED STATES, March 20, 2025 /EINPresswire.com/ — Lumea, a leader in digital pathology solutions. AIRA Matrix Private Limited, an innovative technology company for AI-based diagnostic, prognostic, and predictive…
Lumea’s Digital Diagnostic Suite™ (Viewer+™) Receives FDA 510(k) Clearance* for Clinical Diagnosis LEHI, UTAH, UNITED STATES, March 18, 2025 /EINPresswire.com/ – Lumea, a leader in digital pathology solutions, is proud…
We’re excited to introduce the Digital Diagnostic Digest, a quarterly publication showcasing advancements in digital pathology and real-world applications with practical solutions. After seeing the year-over-year success of the Digital…
